Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancer.

Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancer.

Item
http://www.wikidata.org/entity/Q37562550
Hospital use among patients with lung cancer complicated by bone metastases and skeletal- related events: a population-based cohort study in Denmark.Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006.Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis.LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycleImproving progression-free and overall survival in patients with cancer: a potential role for bisphosphonates.Sternal kyphoplasty for metastatic lung cancer: image-guided palliative care, utilizing fluoroscopy and sonography.Evaluation of the relevance of surgery in a retrospective case series of patients who underwent the surgical treatment of a symptomatic spine metastasis from lung cancer.Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.[Advances on mechanisms of coagulation with non-small cell lung cancer].Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer.
P2860

Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancer.

Item
http://www.wikidata.org/entity/Q37562550
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Skeletal disease contributes s ...... in patients with lung cancer.
@en
Skeletal disease contributes s ...... in patients with lung cancer.
@nl
type
label
Skeletal disease contributes s ...... in patients with lung cancer.
@en
Skeletal disease contributes s ...... in patients with lung cancer.
@nl
prefLabel
Skeletal disease contributes s ...... in patients with lung cancer.
@en
Skeletal disease contributes s ...... in patients with lung cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Skeletal disease contributes s ...... in patients with lung cancer.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698